Trial intelligence / Profile preview

Comparison of Xalatan to Generic Latanoprost in Open Angle Glaucoma

NCT02792803Phase 4Unknown

Start
Sep 2015
Primary completion
Apr 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of latanoprost in primary open-angle glaucoma (POAG), ocular hypertension. Status: unknown.

02

Drugs

latanoprost
03

Conditions

primary open-angle glaucoma (POAG)ocular hypertension

Beyond the preview

Go deeper on NCT02792803.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02792803.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call